I can't help thinking of the numbers of people that have died with COVID particularly in the UK / USA and we've had this "secret weapon" available for months now. However, there is a certain protocol that needs to be followed and so new drugs obviously cannot be rushed into the market, I'm fully aware of that.
If there ever was a case for a promising drug to be expedited though, this is definitely it given both the safety profile of the components making up IHL-675A and the stunning results witnessed in all trials. HCQ has already been FDA approved and CBD has at worst very negligible side effects. The trial results for other respiratory conditions, bronchitis, asthma and COPD also look to be extremely promising and this can only really strengthen our case.
I'd be expecting a response from the FDA in the VERY near future
IHL Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held